‹ All Posts
Pankaj pawar

3rd Aug · SEBI-Registered Analyst

$DRREDDY

**USFDA Approvals & Major Order Win** ** $DRREDDY :** Received **US FDA approval** for its **Rituximab biosimilar** for the U.S. market, used to treat blood cancers and autoimmune diseases. **Impact:** **Positive;** strengthens the biosimilars portfolio and expands opportunities in the U.S. market. ** $RAILTEL :** Secured a **major IaaS (Infrastructure-as-a-Service) order** from **IRCTC** to provide IT infrastructure services. **Impact:** **Positive;** boosts the order book and enhances revenue visibility from digital infrastructure projects. ** $LUPIN :** Received **US FDA approval** for its **Diazepam Injection USP** after the approval of its ANDA. **Impact:** **Positive;** expands the U.S. injectable product portfolio and supports future revenue growth.

#StockInNews#HiddenGems#FundamentalViews#EquityResearch
1,122 likes·73 comments